[Internal] Data Visualization Video   Dr. Gus Gazzard thumbnail Science Saves Sight Prof. Gus Gazzard on SLT vs. Drops for Glaucoma and IOP Control

Science Saves Sight: Prof. Gus Gazzard, the LiGHT Trial and SLT vs. Drops for Glaucoma

How does SLT compare to eye drops for glaucoma treatment? Prof. Gus Gazzard (UK), chief investigator of the LiGHT Trial, reveals eye-opening findings on IOP reduction, disease progression, and adherence. With SLT showing 100% compliance, this raises critical questions about the future of glaucoma care. Explore these insights during Glaucoma Awareness Month.

Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments